December 19, 2011
Takeda Pharmaceutical announced on December 16 that the company has decided not to commercialize its investigational treatment peginesatide for patients with anemia due to chronic kidney disease (CKD) in Japan. Although the company owns its exclusive worldwide development and commercialization...read more